Carl Zeiss Meditec AG

BRSE:001055489 Stock Report

Market Cap: CHF 4.9b

Carl Zeiss Meditec Valuation

Is 001055489 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

4/6

Valuation Score 4/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 001055489 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 001055489 (CHF174.6) is trading below our estimate of fair value (CHF189.28)

Significantly Below Fair Value: 001055489 is trading below fair value, but not by a significant amount.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for 001055489?

Key metric: As 001055489 is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for 001055489. This is calculated by dividing 001055489's market cap by their current earnings.
What is 001055489's PE Ratio?
PE Ratio25.7x
Earnings€203.20m
Market Cap€5.23b

Price to Earnings Ratio vs Peers

How does 001055489's PE Ratio compare to its peers?

The above table shows the PE ratio for 001055489 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average75.6x
MOVE Medacta Group
42.9x18.4%CHF 2.3b
STMN Straumann Holding
61.4x20.9%CHF 17.7b
SOON Sonova Holding
31.3x8.7%CHF 18.8b
MED Medartis Holding
166.9x51.7%CHF 673.0m
001055489 Carl Zeiss Meditec
25.7x16.3%CHF 5.2b

Price-To-Earnings vs Peers: 001055489 is good value based on its Price-To-Earnings Ratio (25.7x) compared to the peer average (75.6x).

Price to Earnings Ratio vs Industry

How does 001055489's PE Ratio compare vs other companies in the European Medical Equipment Industry?

3 CompaniesPrice / EarningsEstimated GrowthMarket Cap
001055489 25.7xIndustry Avg. 29.7xNo. of Companies8PE01632486480+
3 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: 001055489 is good value based on its Price-To-Earnings Ratio (25.7x) compared to the European Medical Equipment industry average (29.7x).

Price to Earnings Ratio vs Fair Ratio

What is 001055489's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

001055489 PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio25.7x
Fair PE Ratio27.6x

Price-To-Earnings vs Fair Ratio: 001055489 is good value based on its Price-To-Earnings Ratio (25.7x) compared to the estimated Fair Price-To-Earnings Ratio (27.6x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.

Discover undervalued companies

Becton Dickinson

US$66.7b

Develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide.

912061

US$238.02

7D

0%

1Y

-2.2%

Galenica

CHF 3.7b

Operates as a healthcare service provider in Switzerland and internationally.

GALE

CHF 75.00

7D

-1.6%

1Y

6.5%

Abbott Laboratories

US$201.0b

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide.

ABT

US$93.50

7D

0%

1Y

2.7%